Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Charles

Showing results (421-430 of 453) with videos related to

Pageof 46
Sort By:
Scientific Reports|August 19, 2018
An Evaluation of the Collagen Fragments Related to Fibrogenesis and Fibrolysis in Nonalcoholic SteatohepatitisYi Luo, Abdul Oseini, Robert Gagnon, et al.
Dermatology and Therapy|April 26, 2019
Skin Bleaching Among African and Afro-Caribbean Women in New York City: Primary Findings from a P30 Pilot StudyEmma K T Benn, Richa Deshpande, Ogonnaya Dotson-Newman, et al.
Methods in Molecular Biology (Clifton, N.J.)|August 22, 2013
Identification of protein biomarkers in human serum using iTRAQ and shotgun mass spectrometryTheodoros A Koutroukides, Julian A J Jaros, Bob Amess, et al.
BMC Infectious Diseases|March 21, 2024
Predictors of severity and prolonged hospital stay of viral acute respiratory infections (ARI) among children under five years in Burkina Faso, 2016-2019Abdoul Kader Ilboudo, Assana Cissé, Jennifer Milucky, et al.
Scientific Reports|June 6, 2018
Proteo-metabolomics reveals compensation between ischemic and non-injured contralateral kidneys after reperfusionHonglei Huang, Leon F A van Dullemen, Mohammed Z Akhtar, et al.
BMJ Open Respiratory Research|December 31, 2021
Phase 2 trial design of BMS-986278, a lysophosphatidic acid receptor 1 (LPA<sub>1</sub>) antagonist, in patients with idiopathic pulmonary fibrosis (IPF) or progressive fibrotic interstitial lung disease (PF-ILD)Tamera J Corte, Lisa Lancaster, Jeffrey J Swigris, et al.
Contemporary Clinical Trials|March 3, 2021
The FALCON program: Two phase 2b randomized, double-blind, placebo-controlled studies to assess the efficacy and safety of pegbelfermin in the treatment of patients with nonalcoholic steatohepatitis and bridging fibrosis or compensated cirrhosisManal F Abdelmalek, Edgar D Charles, Arun J Sanyal, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 3, 2020
Male reproductive aging arises via multifaceted mating-dependent sperm and seminal proteome declines, but is postponable in <i>Drosophila</i>Irem Sepil, Ben R Hopkins, Rebecca Dean, et al.
Journal of Magnetic Resonance Imaging : JMRI|January 29, 2022
Evaluation of a PEGylated Fibroblast Growth Factor 21 Variant Using Novel Preclinical Magnetic Resonance Imaging and Magnetic Resonance Elastography in a Mouse Model of Nonalcoholic SteatohepatitisHaiying Tang, Jiahui Li, Bradley Zinker, et al.
European Journal of Immunology|October 16, 2015
Defining the HLA class I-associated viral antigen repertoire from HIV-1-infected human cellsNicola Ternette, Hongbing Yang, Thomas Partridge, et al.
Pageof 46

Showing results (421-430 of 453) with videos related to

Sort By:
Pageof 46
Scientific Reports|August 19, 2018
An Evaluation of the Collagen Fragments Related to Fibrogenesis and Fibrolysis in Nonalcoholic SteatohepatitisYi Luo, Abdul Oseini, Robert Gagnon, et al.
Dermatology and Therapy|April 26, 2019
Skin Bleaching Among African and Afro-Caribbean Women in New York City: Primary Findings from a P30 Pilot StudyEmma K T Benn, Richa Deshpande, Ogonnaya Dotson-Newman, et al.
Methods in Molecular Biology (Clifton, N.J.)|August 22, 2013
Identification of protein biomarkers in human serum using iTRAQ and shotgun mass spectrometryTheodoros A Koutroukides, Julian A J Jaros, Bob Amess, et al.
BMC Infectious Diseases|March 21, 2024
Predictors of severity and prolonged hospital stay of viral acute respiratory infections (ARI) among children under five years in Burkina Faso, 2016-2019Abdoul Kader Ilboudo, Assana Cissé, Jennifer Milucky, et al.
Scientific Reports|June 6, 2018
Proteo-metabolomics reveals compensation between ischemic and non-injured contralateral kidneys after reperfusionHonglei Huang, Leon F A van Dullemen, Mohammed Z Akhtar, et al.
BMJ Open Respiratory Research|December 31, 2021
Phase 2 trial design of BMS-986278, a lysophosphatidic acid receptor 1 (LPA<sub>1</sub>) antagonist, in patients with idiopathic pulmonary fibrosis (IPF) or progressive fibrotic interstitial lung disease (PF-ILD)Tamera J Corte, Lisa Lancaster, Jeffrey J Swigris, et al.
Contemporary Clinical Trials|March 3, 2021
The FALCON program: Two phase 2b randomized, double-blind, placebo-controlled studies to assess the efficacy and safety of pegbelfermin in the treatment of patients with nonalcoholic steatohepatitis and bridging fibrosis or compensated cirrhosisManal F Abdelmalek, Edgar D Charles, Arun J Sanyal, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 3, 2020
Male reproductive aging arises via multifaceted mating-dependent sperm and seminal proteome declines, but is postponable in <i>Drosophila</i>Irem Sepil, Ben R Hopkins, Rebecca Dean, et al.
Journal of Magnetic Resonance Imaging : JMRI|January 29, 2022
Evaluation of a PEGylated Fibroblast Growth Factor 21 Variant Using Novel Preclinical Magnetic Resonance Imaging and Magnetic Resonance Elastography in a Mouse Model of Nonalcoholic SteatohepatitisHaiying Tang, Jiahui Li, Bradley Zinker, et al.
European Journal of Immunology|October 16, 2015
Defining the HLA class I-associated viral antigen repertoire from HIV-1-infected human cellsNicola Ternette, Hongbing Yang, Thomas Partridge, et al.
Pageof 46